PPIDT00135
Drug Information
| Name | Ancrod |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB05099 |
| Type | biotech |
| Indication | Ancrod is indicated for the treatment of deep vein thrombosis (DVT), central retinal branch vein thrombosis, pripaism, pulmonary hypertension of embolic origin, embolism after insertion of prosthetic cardiac valves, rethrombosis after thrombolytic therapy, rethrombosis after vascular surgery, and prevention of DVT after repair of a fractured neck of a femur. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Liquid | Intravenous; Subcutaneous |
70 unit / mL
|